Bacteroides fragilis capsular polysaccharide A helps heal ulcerative colitis in rats
Author Information
Author(s): Zhong Yijia, Chang Xiujuan, Zhao Zihan, Zheng Lijun, Kuang Gaobo, Li Ping, Liu Chenxuexuan, Fan Yuqin, Liang Zhixuan, Zhuang Ke, Xie Qiuling, Liu Yangyang
Primary Institution: College of Life Science and Technology, Jinan University, Guangzhou, China
Hypothesis
Can capsular polysaccharide A from Bacteroides fragilis improve ulcerative colitis by restoring intestinal barrier integrity and gut microbiota?
Conclusion
The study found that capsular polysaccharide A significantly alleviates ulcerative colitis in rats by restoring intestinal barrier function and gut microbiota.
Supporting Evidence
- TP2 treatment significantly reduced weight loss and improved clinical scores in UC rats.
- TP2 restored intestinal barrier integrity by regulating tight junction proteins.
- TP2 modulated inflammatory cytokine levels, promoting anti-inflammatory responses.
Takeaway
A special sugar from a friendly gut bacteria can help sick rats feel better by fixing their tummy walls and making their good bacteria grow again.
Methodology
Rats were treated with capsular polysaccharide A after inducing colitis with TNBS, and various health indicators were measured.
Limitations
The study was conducted only in rats, and results may not directly translate to humans.
Participant Demographics
Male Wistar rats, six weeks old.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website